← Eichor
Condition: Hereditary Spastic Paraplegia Type 50 Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Hereditary Spastic Paraplegia Type 50

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Melpida: Recombinant Adeno-associated Virus (Serotype 9) Encoding a Codon Optimized Human AP4M1 Transgene (hAP4M1opt)
Phase 1/Phase 2 · 1 location(s) · Elpida Therapeutics SPC · NCT05518188Phase 3 Efficacy Study With Concurrent Control of IT MELPIDA in SPG50.Concurrent Controls.
Phase 3 · 2 location(s) · Elpida Therapeutics SPC · NCT06692712
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.